LOTUSEYENSELotus Eye Hospital and Institute Limited· MiscellaneousMinimalNeutral
Announced Wed, 27 May · 11:02 IST

LOTUSEYE: Lotus Eye Hospital and Institute Limited has informed the Exchange about Copy of Newspaper Publication regarding the Standalone Audited Financial Results.

LOTUSEYE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-1.7%1-day move
₹110.85
prior close
₹108.15
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.0+0.0+0.0-1.7-2.6-1.2+1.0-0.8+5.6+20.2+9.6+7.2
Up moveDown movePending
AI summary

Lotus Eye Hospital and Institute Limited has published its audited standalone financial results for the quarter and year ended March 31, 2026. Total income for FY26 stood at Rs. 5,489.03 Lakhs, up from Rs. 5,086.38 Lakhs in the previous year, representing approximately 8% revenue growth. However, net profit after tax declined sharply to just Rs. 8.04 Lakhs from Rs. 73.93 Lakhs in FY25, a drop of about 89%. The Q4 FY26 standalone result showed a net loss of Rs. 31.95 Lakhs versus a profit of Rs. 25.23 Lakhs in Q4 FY25. EPS for FY26 was Rs. 0.04 basic per share compared to Rs. 0.36 in FY25. The Board approved these results at its meeting held on May 26, 2026.

Likely market impact

Despite modest revenue growth, the company experienced a severe contraction in profitability during FY26, which could negatively impact investor sentiment and the stock price in the near term. Shareholders should monitor the company's cost structure and operational efficiency going forward.